Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow

doi:10.1084/jem.148.6.1687

This Article

	Full Text (PDF)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Korngold, B.
	Articles by Sprent, J.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Korngold, B.
	Articles by Sprent, J.


Social Bookmarking

	What's this?

ARTICLES

Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow

B Korngold and J Sprent

In two situations, transfer of normal unsensitized bone marrow cells into heavily irradiated H-2-identical allogeneic mice caused a high incidence of lethal chronic graft-versus-host disease (GVHD), i.e. mortality occuring between days of 20 and 80 postirradiation. Minor histocompatibility determinants appeared to be the main target for eliciting GVHD. Removing mature T cells from the marrow with anti-Thy 1.2 serum and complement before injection prevented GVHD. On the basis of adding purified T cells to T-cell-depleted marrow cells, it was concluded that contamination of the marrow with as few as 0.3% T cells was sufficient to cause a high incidence of lethal GVHD in certain situations. No GVHD was found with the injection of non-T cells (Thy 1.2-negative cells) or with tolerant T cells. Irradiated recipients of T-cell-depleted marrow cells remained in good health for prolonged periods. These mice showed extensive chimerism with respect to the donor marrow, normal numbers of T and B cells and were immunocompetent. The data provide no support for the view that chronic GVHD developing after bone marrow transplantation in man is the result of an attack by the progeny of the donor stem cells. The results imply that mature T cells contaminating marrow inocula are probably the main cause of GVHD seen in the clinical situation.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Chakraverty, R., Sykes, M. (2007). The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia. Blood 110: 9-17 [Abstract] [Full Text]
Chen, B. J., Deoliveira, D., Cui, X., Le, N. T., Son, J., Whitesides, J. F., Chao, N. J. (2007). Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse. Blood 109: 3115-3123 [Abstract] [Full Text]
Bashyam, H. (2007). Crossing barriers in transplantation. J. Exp. Med. 204: 459-459 [Abstract] [Full Text]
Mullally, A., Ritz, J. (2007). Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation. Blood 109: 1355-1362 [Abstract] [Full Text]
Sakoda, Y., Hashimoto, D., Asakura, S., Takeuchi, K., Harada, M., Tanimoto, M., Teshima, T. (2007). Donor-derived thymic-dependent T cells cause chronic graft-versus-host disease. Blood 109: 1756-1764 [Abstract] [Full Text]
Olson, T. S., Reuter, B. K., Scott, K. G-E., Morris, M. A., Wang, X.-M., Hancock, L. N., Burcin, T. L., Cohn, S. M., Ernst, P. B., Cominelli, F., Meddings, J. B., Ley, K., Pizarro, T. T. (2006). The primary defect in experimental ileitis originates from a nonhematopoietic source. J. Exp. Med. 203: 541-552 [Abstract] [Full Text]
Alpdogan, O., Hubbard, V. M., Smith, O. M., Patel, N., Lu, S., Goldberg, G. L., Gray, D. H., Feinman, J., Kochman, A. A., Eng, J. M., Suh, D., Muriglan, S. J., Boyd, R. L., van den Brink, M. R. M. (2006). Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration. Blood 107: 2453-2460 [Abstract] [Full Text]
Alpdogan, O., Eng, J. M., Muriglan, S. J., Willis, L. M., Hubbard, V. M., Tjoe, K. H., Terwey, T. H., Kochman, A., van den Brink, M. R. M. (2005). Interleukin-15 enhances immune reconstitution after allogeneic bone marrow transplantation. Blood 105: 865-873 [Abstract] [Full Text]
Ghansah, T., Paraiso, K. H. T., Highfill, S., Desponts, C., May, S., McIntosh, J. K., Wang, J.-W., Ninos, J., Brayer, J., Cheng, F., Sotomayor, E., Kerr, W. G. (2004). Expansion of Myeloid Suppressor Cells in SHIP-Deficient Mice Represses Allogeneic T Cell Responses. J. Immunol. 173: 7324-7330 [Abstract] [Full Text]
Sugerman, P. B., Faber, S. B., Willis, L. M., Petrovic, A., Murphy, G. F., Pappo, J., Silberstein, D., van den Brink, M. R. M. (2004). Kinetics of Gene Expression in Murine Cutaneous Graft-versus-Host Disease. Am. J. Pathol. 164: 2189-2202 [Abstract] [Full Text]
Chen, B. J., Cui, X., Sempowski, G. D., Liu, C., Chao, N. J. (2004). Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease. Blood 103: 1534-1541 [Abstract] [Full Text]
Petrovic, A., Alpdogan, O., Willis, L. M., Eng, J. M., Greenberg, A. S., Kappel, B. J., Liu, C., Murphy, G. J., Heller, G., van den Brink, M. R. M. (2004). LPAM ({alpha}4{beta}7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease. Blood 103: 1542-1547 [Abstract] [Full Text]
Liu, J., Heuer, J. G., Na, S., Galbreath, E., Zhang, T., Yang, D. D., Glasebrook, A., Song, H. Y. (2002). Accelerated Onset and Increased Severity of Acute Graft-Versus-Host Disease Following Adoptive Transfer of DR6-Deficient T Cells. J. Immunol. 169: 3993-3998 [Abstract] [Full Text]
Kim, J. C., Whitaker-Menezes, D., Deguchi, M., Adair, B. S., Korngold, R., Murphy, G. F. (2002). Novel Expression of Vascular Cell Adhesion Molecule-1 (CD106) by Squamous Epithelium in Experimental Acute Graft-versus-Host Disease. Am. J. Pathol. 161: 763-770 [Abstract] [Full Text]
Zhang, Y., McCormick, L. L., Desai, S. R., Wu, C., Gilliam, A. C. (2002). Murine Sclerodermatous Graft-Versus-Host Disease, a Model for Human Scleroderma: Cutaneous Cytokines, Chemokines, and Immune Cell Activation. J. Immunol. 168: 3088-3098 [Abstract] [Full Text]
Ho, V. T., Soiffer, R. J. (2001). The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood 98: 3192-3204 [Full Text]
Alpdogan, O., Schmaltz, C., Muriglan, S. J., Kappel, B. J., Perales, M.-A., Rotolo, J. A., Halm, J. A., Rich, B. E., van den Brink, M. R. M. (2001). Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease. Blood 98: 2256-2265 [Abstract] [Full Text]
Jiang, Z., Podack, E., Levy, R. B. (2001). Major histocompatibility complex-mismatched allogeneic bone marrow transplantation using perforin and/or Fas ligand double-defective CD4+ donor T cells: involvement of cytotoxic function by donor lymphocytes prior to graft-versus-host disease pathogenesis. Blood 98: 390-397 [Abstract] [Full Text]
McCormick, L. L., Zhang, Y., Tootell, E., Gilliam, A. C. (1999). Anti-TGF-{beta} Treatment Prevents Skin and Lung Fibrosis in Murine Sclerodermatous Graft-Versus-Host Disease: A Model for Human Scleroderma. J. Immunol. 163: 5693-5699 [Abstract] [Full Text]
Bobe, P., Benihoud, K., Grandjon, D., Opolon, P., Pritchard, L. L., Huchet, R. (1999). Nitric Oxide Mediation of Active Immunosuppression Associated With Graft-Versus-Host Reaction. Blood 94: 1028-1037 [Abstract] [Full Text]
Zeng, D., Lewis, D., Dejbakhsh-Jones, S., Lan, F., Garcia-Ojeda, M., Sibley, R., Strober, S. (1999). Bone Marrow NK1.1- and NK1.1+ T Cells Reciprocally Regulate Acute Graft versus Host Disease. J. Exp. Med. 189: 1073-1081 [Abstract] [Full Text]
Cooke, K. R., Krenger, W., Hill, G., Martin, T. R., Kobzik, L., Brewer, J., Simmons, R., Crawford, J. M., van den Brink, M. R.M., Ferrara, J. L.M. (1998). Host Reactive Donor T Cells Are Associated With Lung Injury After Experimental Allogeneic Bone Marrow Transplantation. Blood 92: 2571-2580 [Abstract] [Full Text]
Adler, H., Beland, J. L., Kozlow, W., Del-Pan, N. C., Kobzik, L., Rimm, I. J. (1998). A Role for Transforming Growth Factor-beta 1 in the Increased Pneumonitis in Murine Allogeneic Bone Marrow Transplant Recipients With Graft-Versus-Host Disease After Pulmonary Herpes Simplex Virus Type 1�Infection. Blood 92: 2581-2589 [Abstract] [Full Text]
Friedman, T. M., Gilbert, M., Briggs, C., Korngold, R. (1998). Repertoire Analysis of CD8+ T Cell Responses to Minor Histocompatibility Antigens Involved in Graft-Versus-Host Disease. J. Immunol. 161: 41-48 [Abstract] [Full Text]
Sedgwick, J. D., Ford, A. L., Foulcher, E., Airriess, R. (1998). Central Nervous System Microglial Cell Activation and Proliferation Follows Direct Interaction with Tissue-Infiltrating T Cell Blasts. J. Immunol. 160: 5320-5330 [Abstract] [Full Text]
Shankar, G., Scott Bryson, J., Darrell Jennings, C., Morris, P. E., Cohen, D. A. (1998). Idiopathic Pneumonia Syndrome in Mice after Allogeneic Bone Marrow Transplantation. Am. J. Respir. Cell Mol. Bio. 18: 235-242 [Abstract] [Full Text]
Henslee-Downey, P. J., Abhyankar, S. H., Parrish, R. S., Pati, A. R., Godder, K. T., Neglia, W. J., Goon-Johnson, K. S., Geier, S. S., Lee, C. G., Gee, A. P. (1997). Use of Partially Mismatched Related Donors Extends Access to Allogeneic Marrow Transplant. Blood 89: 3864-3872 [Abstract] [Full Text]
Ferrara, J., Cooke, K., Pan, L, Krenger, W (1996). The immunopathophysiology of acute graft-versus-host-disease. Stem Cells 14: 473-489 [Abstract]
Vallera, D., Ash, R., Zanjani, E., Kersey, J., LeBien, T., Beverley, P., Neville, D. Jr, Youle, R. (1983). Anti-T-cell reagents for human bone marrow transplantation: ricin linked to three monoclonal antibodies. Science 222: 512-515 [Abstract]
Vitetta, E., Krolick, K., Miyama-Inaba, M, Cushley, W, Uhr, J. (1983). Immunotoxins: a new approach to cancer therapy. Science 219: 644-650